Chunguang Yang

First Affiliated Hospital of Guangzhou Medical University — China

Medicine · Health Sciences

25h-index2.3kcitations119works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(20), Influenza Virus Research Studies(18), COVID-19 Clinical Research Studies(15), Prostate Cancer Treatment and Research(15), SARS-CoV-2 and COVID-19 Research(13)

Publications119 total

Design, synthesis and pharmacological evaluation of phenylthiophene-2-carboxamide-based RSV fusion protein inhibitors
Bioorganic Chemistry·2026
Tripartite Risk Stratification of Clinically Significant Prostate Cancer in Elevated PSA Patients: Reducing Unnecessary Biopsy through Multimodal Ensemble Learning
SSRN Electronic Journal·2026Open Access
Cathepsin S contributes to influenza-induced lung injury by driving inflammation, promoting apoptosis, and disrupting epithelial barrier integrity
Microbiology Spectrum·2025Open Access
Efficacy and Safety of Disitamab Vedotin Combined with Gemcitabine as Neoadjuvant Therapy in Muscle-invasive Bladder Cancer: An Open-label, Multicenter, Single-arm, Phase 2 Trial
European Urology·2025· 1 cited
Comparison of Perioperative, Oncological, and Functional Outcomes of Robot-Assisted Laparoscopic Radical Prostatectomy With or Without Biopsy
JU Open Plus·2025· 1 citedOpen Access
Multimodal Nomogram Combining Multiparametric MRI, Functional Subsets of Peripheral Lymphocytes and PI-RADS Can Predict Risk Stratification of Prostate Cancer
Computer Methods and Programs in Biomedicine·2025
N460S in PB2 and I163T in nucleoprotein synergistically enhance the viral replication and pathogenicity of influenza B virus
PLoS Pathogens·2025· 1 citedOpen Access
Immunological synapse: structures, molecular mechanisms and therapeutic implications in disease
Signal Transduction and Targeted Therapy·2025· 13 citedOpen Access
Risk factors and therapeutic significance of HER2 overexpression in urothelial carcinoma
Pathology - Research and Practice·2025
Genetically predicted benign prostate hyperplasia causally affects prostate cancer: a two-sample Mendelian randomization
Translational Andrology and Urology·2025· 1 citedOpen Access
Biomarkers in metastatic castration-resistant prostate cancer for efficiency of immune checkpoint inhibitors
Annals of Medicine·2025· 9 citedOpen Access
Process-driven strength enhancement and progressive damage analysis of three-dimensional woven composites traction rods
Materials & Design·2025· 5 citedOpen Access
Early Diagnosis of Urothelial Carcinoma Using Urinary Extracellular Vesicles
SSRN Electronic Journal·2025Open Access
Generative Prostate MRI Synthesis based on Latent Diffusion model for prostate cancer risk stratification
2024· 2 cited
Simultaneous imaging of telomerase activity and protein tyrosine kinase 7 in living cells during epithelial-mesenchymal transformation via a near-infrared light-activatable nanoprobe
Talanta·2024
Partial prostatectomy for localized prostate cancer
World Journal of Urology·2024· 2 cited
Data from CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer
2024Open Access
Data from CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer
2024Open Access
Supplementary Data from CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer
2024Open Access
Supplementary Data from CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer
2024Open Access
page 1 of 6Next →

Frequent Co-authors

Zhiquan Hu(19), Zhihua Wang(16), Zifeng Yang(13), Xing Zeng(12), Chunjin Ke(8), Jun Xiao(7), Shaogang Wang(7), Nanshan Zhong(7), Haiming Jiang(5), Yutao Wang(5), Runfeng Li(5), Xueyou Ma(4), Jin Zhao(4), Qiuling Du(4), Jianbo Tian(3), Qiang Zhong(3), Zequn Lu(3), Yanan Wang(3), Xiang‐Ping Yang(3), Zhangqun Ye(3)